Basics Sagimet Biosciences Inc. Series A IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $207.81M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 4.89% Avg Daily Range (30 D): $0.30 | 3.81% Avg Daily Range (90 D): $0.28 | 3.65% Institutional Daily Volume Avg Daily Volume: .74M Avg Daily Volume (30 D): .53M Avg Daily Volume (90 D): .53M Trade Size Avg Trade Size (Sh.): 123 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 64 Avg Inst. Trade: $1.31M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.66M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.51M Avg Closing Trade (30 D): $.88M Avg Closing Trade (90 D): $.88M Avg Closing Volume: 442.39K     News Oct 24, 2025 @ 11:00 AM Denifanstat Achieved All Endpoints in the Treatmen... Source: Sagimet Biosciences Sep 17, 2025 @ 11:00 AM Positive Phase 3 Results for Denifanstat for the T... Source: Sagimet Biosciences Inc. Sep 10, 2025 @ 11:00 AM Sagimet Biosciences Announces Upcoming Presentatio... Source: Sagimet Biosciences Aug 5, 2025 @ 11:00 AM Sagimet Biosciences to Participate in the Canaccor... Source: Sagimet Biosciences Jun 9, 2025 @ 11:00 AM Sagimet Biosciences to Host Virtual KOL Event, ââ... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.4 $-.56 Diluted EPS $-.4 $-.56 Revenue $ M $ $ M Gross Profit $ $ $ Net Income / Loss $ -12.91M $ -10.39M $ -18.18M Operating Income / Loss $ -14.33M $ $ -19.87M Cost of Revenue $ $ $ Net Cash Flow $ $ $ M PE Ratio